ES2036670T3 - Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante. - Google Patents

Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante.

Info

Publication number
ES2036670T3
ES2036670T3 ES198888300771T ES88300771T ES2036670T3 ES 2036670 T3 ES2036670 T3 ES 2036670T3 ES 198888300771 T ES198888300771 T ES 198888300771T ES 88300771 T ES88300771 T ES 88300771T ES 2036670 T3 ES2036670 T3 ES 2036670T3
Authority
ES
Spain
Prior art keywords
sensitizing
corticoesteroid
pharmacy
composition
prevent
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Expired - Lifetime
Application number
ES198888300771T
Other languages
English (en)
Inventor
Alfred Amkraut
Jane E. Shaw
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Alza Corp
Original Assignee
Alza Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Alza Corp filed Critical Alza Corp
Application granted granted Critical
Publication of ES2036670T3 publication Critical patent/ES2036670T3/es
Anticipated expiration legal-status Critical
Expired - Lifetime legal-status Critical Current

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/70—Web, sheet or filament bases ; Films; Fibres of the matrix type containing drug
    • A61K9/7023—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms
    • A61K9/703—Transdermal patches and similar drug-containing composite devices, e.g. cataplasms characterised by shape or structure; Details concerning release liner or backing; Refillable patches; User-activated patches
    • A61K9/7084—Transdermal patches having a drug layer or reservoir, and one or more separate drug-free skin-adhesive layers, e.g. between drug reservoir and skin, or surrounding the drug reservoir; Liquid-filled reservoir patches
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/56—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids
    • A61K31/57—Compounds containing cyclopenta[a]hydrophenanthrene ring systems; Derivatives thereof, e.g. steroids substituted in position 17 beta by a chain of two carbon atoms, e.g. pregnane or progesterone
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P37/00—Drugs for immunological or allergic disorders
    • A61P37/08—Antiallergic agents

Landscapes

  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Health & Medical Sciences (AREA)
  • Veterinary Medicine (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Dermatology (AREA)
  • Epidemiology (AREA)
  • Pulmonology (AREA)
  • Immunology (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Medicinal Preparation (AREA)
  • Steroid Compounds (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)

Abstract

LA INVENCION SE REFIERE A UN METODO PARA PREVENIR LA SENSIBILIZACION EN LA LIBERACION TRANSDERMICA DE FARMACOS POR LA INCLUSION DE UN CORTICOSTEROIDE QUE PUEDE SER COADMINISTRADO CON EL AGENTE SENSIBILIZANTE.
ES198888300771T 1987-03-09 1988-01-29 Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante. Expired - Lifetime ES2036670T3 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US2358387A 1987-03-09 1987-03-09

Publications (1)

Publication Number Publication Date
ES2036670T3 true ES2036670T3 (es) 1993-06-01

Family

ID=21816005

Family Applications (1)

Application Number Title Priority Date Filing Date
ES198888300771T Expired - Lifetime ES2036670T3 (es) 1987-03-09 1988-01-29 Composicion para prevenir una alergia de contacto por administracion simultanea de un corticoesteroide con un farmaco sensibilizante.

Country Status (5)

Country Link
EP (1) EP0282156B1 (es)
JP (1) JP2725776B2 (es)
CA (1) CA1294549C (es)
DE (1) DE3862405D1 (es)
ES (1) ES2036670T3 (es)

Families Citing this family (12)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US5026556A (en) * 1988-11-10 1991-06-25 Norwich Eaton Pharmaceuticals, Inc. Compositions for the transdermal delivery of pharmaceutical actives
DE69033541D1 (de) * 1989-09-25 2000-06-15 Univ Utah Res Found Verwendung von steroidhormonen in zubereitungen zur induzierung von t-zell-lymphokin-erzeugung
US5919465A (en) * 1989-09-25 1999-07-06 University Of Utah Research Foundation Methods for augmenting immunological responses through the administration of dehydroepiandrosterone (DHEA) and dehydroepiandrosterone-sulfate (DHEA-S)
US5096715A (en) * 1989-11-20 1992-03-17 Alko Ltd. Method and means for treating alcoholism by extinguishing the alcohol-drinking response using a transdermally administered opiate antagonist
DE3939376C1 (es) * 1989-11-29 1991-05-08 Lts Lohmann Therapie-Systeme Gmbh & Co. Kg, 5450 Neuwied, De
US5069909A (en) * 1990-06-20 1991-12-03 Cygnus Therapeutic Systems Transdermal administration of buprenorphine
US5120545A (en) * 1990-08-03 1992-06-09 Alza Corporation Reduction or prevention of sensitization to drugs
US5736537A (en) 1995-09-12 1998-04-07 Estee Lauder, Inc. Dehydroep:androsterone sailcylate useful against skin atrophy
IT1309588B1 (it) * 1999-03-05 2002-01-24 Altergon Sa Cerotto con spessore sottile contenente betametasone ed acidoialuronico per il trattamento di psoriasi, dermatite, dermatosi.
US6383511B1 (en) * 1999-10-25 2002-05-07 Epicept Corporation Local prevention or amelioration of pain from surgically closed wounds
JP2011507904A (ja) * 2007-12-21 2011-03-10 ザーズ ファーマ， インコーポレイテッド アルプラゾラムおよび他の薬物を経皮送達するためのパッチ、製剤および関連する方法
US9211397B2 (en) 2012-12-19 2015-12-15 Senju Usa, Inc. Patch for treatment of eyelid disease containing clobetasol

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
NL7707501A (nl) * 1976-08-12 1978-02-14 Knoll Ag Uitwendig toe te dienen geneesmiddelpreparaat.
ATE12731T1 (de) * 1979-01-11 1985-05-15 Key Pharma Polymere diffusionsmatrix und verfahren zu deren herstellung.
JPS58113275A (ja) * 1981-12-28 1983-07-06 Nichiban Co Ltd 感圧性接着剤組成物
JPS6023312A (ja) * 1983-07-15 1985-02-05 Nitto Electric Ind Co Ltd 医薬製剤
JPS6069016A (ja) * 1983-09-27 1985-04-19 Nitto Electric Ind Co Ltd 粘着貼付製剤
CA1248450A (en) * 1984-04-05 1989-01-10 Kazuo Kigasawa Soft patch
JPS61151122A (ja) * 1984-12-25 1986-07-09 Sekisui Chem Co Ltd 外用貼付剤
CA1272445A (en) * 1985-02-25 1990-08-07 Yie W. Chien Transdermal pharmaceutical absorption dosage unit and process of pharmaceutical administration

Also Published As

Publication number Publication date
EP0282156A2 (en) 1988-09-14
CA1294549C (en) 1992-01-21
EP0282156B1 (en) 1991-04-17
JPS63230635A (ja) 1988-09-27
EP0282156A3 (en) 1988-11-23
DE3862405D1 (de) 1991-05-23
JP2725776B2 (ja) 1998-03-11

Similar Documents

Publication Publication Date Title
AR012671A1 (es) Composiciones farmaceuticas para el tratamiento o profilaxis de la constipacion, los usos de dichas composiciones y los procesos para prepararlos
CO5680109A1 (es) Compuestos para el tratamiento de la disfuncion sexual femenina
ES2185816T3 (es) Formas de dosificacion farmaceutica para la via oral, que comprenden un agente inhibidor de la bomba de protones y un agente procinetico.
ES2111304T3 (es) Composicion de administracion por via nasal de un medicamento que contiene nicotina.
AR037490A1 (es) Composiciones farmaceuticas solidas, proceso para su preparacion, kit para el tratamiento de la obesidad y uso de dichas composiciones en la elaboracion de medicamentos
ES2107235T3 (es) Tableta de liberacion prolongada, revestida con pelicula, de astemizol y pseudoefedrina.
CO5560558A2 (es) Uso de una composicion de celecoxib para rapido alivio del dolor
ES2011120A6 (es) Forma de dosificacion para tratar las enfermedades cardiovasculares.
ES2183945T3 (es) Composiciones para mejorar el aporte de un agente por electrotransporte.
AR035500A1 (es) Uso de clorpromazina y pentamidina para la fabricacion de medicamentos, composicion farmaceutica y paquete farmaceutico que comprenden clorpromazina y pentamidina.
ES2144980T1 (es) Metodos y composiciones para tratar la rinitis alergica y otros trastornos, empleando descarboetoxiloratadina.
ES2037908T3 (es) Un procedimiento para la preparacion de una tableta de capas multiples en una forma de dosificacion unitaria solida.
ES2144119T3 (es) Uso de inhibidores de la ciclooxigenasa no esteroideos para la fabricacion de un medicamento para el tratamiento de una presion intraocular elevada.
AR033342A1 (es) Una composicion otica topica o intranasal para tratar el dolor otico y el uso topico de agonistas de opioides kapa para tratar el dolor otico
ZA852485B (en) Cough/cold mixtures comprising non-steroidal anti-inflammatory drugs
PT841904E (pt) Composicoes farmaceuticas orais com libertacao diferida de inibidores reversiveis da bomba de protoes
NO993520D0 (no) Doseringsformer og fremgangsmåte for å bedre erektil dysfunksjon
ES2176684T3 (es) Nuevas asociaciones de principios activos que contienen clopidogrel y un antitrombotico.
ES2084168T3 (es) Composiciones antimalaricas.
AR042051A1 (es) Tratamiento combinado contra el cancer con un compuesto anti-cancerigeno activado por glutationa s- transferasa (gst) y otro tratamiento contra el cancer
ES2032898T5 (es) Locion de esteroide.
ES507236A0 (es) Un procedimiento para preparar una composicion farmaceutica para aplicacion topica, empleada en el tratamiento del acne.
MX9203557A (es) Una forma de dosis para suministrar el farmaco benefico verapamil.
DE69034070D1 (de) Racemisches Huperzin A
AR006401A1 (es) Compuestos de pirrolopirrolona, una composicion farmaceutica que los contiene, su uso en la fabricacion de un medicamento y en terapia, procesospara su preparación y compuestos intermediarios para dichos procesos.

Legal Events

Date Code Title Description
FG2A Definitive protection

Ref document number: 282156

Country of ref document: ES